Lamotrigine Tablet
Product Images NDC 71335-1179

7 FDA label images from Bryant Ranch Prepack · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Lamotrigine (NDC 71335-1179). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (2d955155 686d 40cd 898e Df7d760247a5 740 1)

FDA Label Image

Image (2d955155 686d 40cd 898e Df7d760247a5 789 2)

Image (2d955155 686d 40cd 898e Df7d760247a5 789 2)
Illustration showing tablet shapes, imprints, and colors of Lamotrigine oral tablets in various strengths by Bryant Ranch Prepack. The 25 mg tablet is white and oblong with imprint 'U 111'. The 100 mg tablet is white and triangular with imprint 'U 112'. The 150 mg tablet is white and triangular with imprint 'U 113'. The 200 mg tablet is light blue and triangular with imprint 'U 114'.*
FDA Label Image

Image (2d955155 686d 40cd 898e Df7d760247a5 789 3)

FDA Label Image

Molecular Structure (Ad7af627 Ea4b 4a78 A71e Db1255416d1e 01)

Molecular Structure (Ad7af627 Ea4b 4a78 A71e Db1255416d1e 01)
Chemical structure of lamotrigine showing a triazine ring with two amino groups and a dichlorophenyl group attached, consistent with the active ingredient lamotrigine.*
FDA Label Image

Figure 1 (Ad7af627 Ea4b 4a78 A71e Db1255416d1e 02)

Figure 1 (Ad7af627 Ea4b 4a78 A71e Db1255416d1e 02)
A survival curve chart depicting failure probability (%) over weeks up to 100 weeks for Lamotrigine and placebo groups. The chart shows two lines labeled 'Lamotrigine' and 'Placebo', with failure probability increasing over time, and markers indicating censored data points.*
FDA Label Image

Figure 2 (Ad7af627 Ea4b 4a78 A71e Db1255416d1e 03)

Figure 2 (Ad7af627 Ea4b 4a78 A71e Db1255416d1e 03)
A Kaplan-Meier failure probability graph comparing Lamotrigine and placebo over time in weeks. The vertical axis shows failure probability (%) from 0 to 100, and the horizontal axis shows weeks from 0 to 80. Two curves represent the failure probabilities for Lamotrigine and placebo groups, with censored data marks indicated.*
FDA Label Image

Label (Lbl713351179)

Label (Lbl713351179)
Label for Lamotrigine 25 mg tablets, an oral prescription drug packaged by Bryant Ranch Prepack in Burbank, CA. The label includes instructions to keep tightly closed and to store at room temperature between 20°-25°C (68°-77°F). It references comparison to Lamictal 25 mg tablets by Unichem Laboratories Ltd and displays the product NDC 71335-1179 with a barcode.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.